Effect of Supplementation with a Specific Probiotic (Bifidobacterium bifidum PRL2010) in Pregnancy for the Prevention of Atopic Dermatitis in Children: Preliminary Results of a Randomized Trial
Nutrients · 2025
DOI: 10.3390/nu17040673 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Caterina Anania und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Bifidobacterium bifidum, Dermatitis, Atopic, Dietary Supplements, Probiotics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by the appearance of recurrent eczematous lesions and intense itching. The World Allergy Organization (WAO) suggested the administration of probiotics in pregnant women at high risk of allergies in their children.
Objectives
Our study aims to evaluate the role of administering the Bifidobacterium bifidum strain PRL2010 during pregnancy and breastfeeding in preventing and/or reducing the severity of AD manifestations in children.
Methods
It is a monocentric, randomized, double-blind, placebo-controlled trial with probiotic/placebo administration since the 36th week of gestation to mothers with atopy or a family history of atopy; the effects were evaluated over the first 12 months of the children’s lives.
Results
No severe adverse effects due to probiotic intake were reported in our cohort. Although proportionally fewer children with AD were in the probiotic group, the statistical analysis showed no significant differences between the probiotic and placebo groups. However, infants who developed the most severe forms of AD in the probiotic group showed a better clinical course during follow-up compared to those in the placebo group.
Conclusions
In conclusion, administering the probiotic Bifidobacterium bifidum strain PRL2010 during pregnancy and breastfeeding is safe and potentially beneficial; further large-scale studies may confirm its usefulness in improving the clinical manifestation of AD in children with a family history of atopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161 Rome, Italy.
- Institute for the Application of Calculus (IAC)-CNR, 00185 Rome, Italy.
- Independent Researcher, 00100 Rome, Italy.
ORCID-Profile: Caterina Anania, Viviana Matys, Daniela De Canditiis, Francesca Olivero
Zitieren
APA
Anania, C., Matys, V., Marra, S., De Canditiis, D., Olivero, F., Carraro, C., Giugliano, A., Zicari, A. M., & Piccioni, M. G. (2025). Effect of Supplementation with a Specific Probiotic (Bifidobacterium bifidum PRL2010) in Pregnancy for the Prevention of Atopic Dermatitis in Children: Preliminary Results of a Randomized Trial. Nutrients. https://doi.org/10.3390/nu17040673
Vancouver
Anania C, Matys V, Marra S, De Canditiis D, Olivero F, Carraro C, et al. Effect of Supplementation with a Specific Probiotic (Bifidobacterium bifidum PRL2010) in Pregnancy for the Prevention of Atopic Dermatitis in Children: Preliminary Results of a Randomized Trial. Nutrients. 2025. doi:10.3390/nu17040673
BibTeX
@article{Anania2025,
author = {Anania, Caterina and Matys, Viviana and Marra, Simona and De Canditiis, Daniela and Olivero, Francesca and Carraro, Carlo and Giugliano, Anna and Zicari, Anna Maria and Piccioni, Maria Grazia},
title = {Effect of Supplementation with a Specific Probiotic (Bifidobacterium bifidum PRL2010) in Pregnancy for the Prevention of Atopic Dermatitis in Children: Preliminary Results of a Randomized Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17040673}
}
EUVIMED